Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cancer Genetics Inc (NASDAQ:CGIX)

2.65
Delayed Data
As of Nov 22
 0.00 / 0.00%
Today’s Change
1.30
Today|||52-Week Range
5.30
+96.30%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues7.2M7.0M6.6M8.0M
 
 
 
 
 
Cost of Goods Sold3.7M3.6M3.5M3.9M
 
 
 
 
 
Depreciation And Amortization613.0K617.0K530.0K523.0K
 
 
 
 
 
 
Operating ExpensesGross Income3.0M2.8M2.6M3.6M
 
 
 
 
 
General Expenses6.4M5.5M5.7M6.6M
 
 
 
 
 
Research And Development1.1M1.1M982.0K979.0K
 
 
 
 
 
Total Operating Expenses10.7M9.8M9.7M11.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.5M-2.8M-3.1M-3.0M
 
 
 
 
 
Extraordinary Credit829.0K0.00590.0K2.9M
 
 
 
 
Extraordinary Charge0.00-7.5M0.00-150.0K
 
 
 
Pre-Tax Equity Earnings-28.0K-12.0K-7.0K-2.0K
 
 
 
 
 
Interest Expense On Debt110.0K194.0K253.0K350.0K
 
 
 
 
 
Other Expenses0.00-46.0K0.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-2.8M-10.6M-2.8M-633.0K
 
 
 
 
 
Income Taxes0.00-970.0K0.000.00
 
 
Net Income-2.8M-9.6M-2.8M-633.0K
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS18.8M18.9M19.7M21.6M
 
 
 
 
 
Shares To Calculate EPS Diluted18.8M18.9M20.7M22.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.15-$0.51-$0.16-$0.15
 
 
 
 
 
EPS Diluted-$0.15-$0.51-$0.16-$0.15